Kiniksa Pharmaceuticals International, plc (KNSA)

KNSA Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	97.38	107.95	122.72	122.47	114.04	46.93
Short-Term Investments	126.4	98.42	67.89	59.73	209.44	186.45
Cash & Short-Term Investments	223.78	206.37	190.61	182.2	323.48	233.38
Cash Growth	11.29%	8.27%	4.61%	-43.68%	38.61%	-24.06%
Receivables	24.89	21.27	20.32	3.99	-	-
Inventory	28.68	31.12	21.6	3.68	-	-
Prepaid Expenses	33.95	17.54	10.54	6.59	9.56	8.25
Restricted Cash	-	-	-	-	0.21	-
Total Current Assets	311.3	276.3	243.06	196.45	333.25	241.63
Property, Plant & Equipment	11.66	12.67	7.04	8.38	10.62	8.33
Other Intangible Assets	16.5	17.25	18.25	19.25	-	-
Long-Term Deferred Tax Assets	207.99	219.28	185.5	-	0.01	4.37
Other Long-Term Assets	7.85	0.83	5.82	8.72	5.59	0.21
Total Assets	555.3	526.32	459.67	232.8	349.46	254.53
Accounts Payable	8.33	8.25	7.9	1.87	0.5	5.69
Accrued Expenses	69.53	44.67	30.11	38.03	29.2	20.42
Current Portion of Leases	2.03	2.25	3.3	3.38	2.11	1.7
Current Unearned Revenue	-	0.31	-	-	-	-
Other Current Liabilities	16.07	8.19	5.75	1.54	0.04	0.03
Total Current Liabilities	95.96	63.67	47.07	44.82	31.85	27.83
Long-Term Leases	8.56	10.01	2.62	2.67	4.88	0.96
Long-Term Unearned Revenue	11.81	11.95	12	-	-	-
Other Long-Term Liabilities	1.96	1.86	1.84	0.27	0.81	0.33
Total Liabilities	118.29	87.48	63.52	47.76	37.53	29.11
Common Stock	0.02	0.02	0.02	0.02	0.02	0.02
Additional Paid-In Capital	949.28	916.76	888.12	860.48	829.42	581.47
Retained Earnings	-512.26	-477.95	-492.03	-675.4	-517.47	-356.09
Comprehensive Income & Other	-0.04	0.01	0.04	-0.07	-0.03	0.03
Total Common Equity	437.01	438.84	396.15	185.04	311.94	225.42
Shareholders' Equity	437.01	438.84	396.15	185.04	311.94	225.42
Total Liabilities & Equity	555.3	526.32	459.67	232.8	349.46	254.53
Total Debt	10.6	12.26	5.92	6.05	6.99	2.65
Net Cash (Debt)	213.19	194.11	184.69	176.15	316.5	230.73
Net Cash Growth	13.32%	5.10%	4.85%	-44.34%	37.17%	-24.92%
Net Cash Per Share	3.01	2.70	2.62	2.57	5.12	4.27
Filing Date Shares Outstanding	72.2	70.62	69.75	69.1	68.23	55.55
Total Common Shares Outstanding	72.16	70.46	69.7	69.06	68.22	54.94
Working Capital	215.35	212.63	195.99	151.62	301.4	213.8
Book Value Per Share	6.06	6.23	5.68	2.68	4.57	4.10
Tangible Book Value	420.51	421.59	377.9	165.79	311.94	225.42
Tangible Book Value Per Share	5.83	5.98	5.42	2.40	4.57	4.10
Machinery	4.56	4.58	4.59	4.65	5.01	5.08
Construction In Progress	0.18	0.01	-	0.17	0.1	0.02
Leasehold Improvements	3.93	3.93	3.93	3.93	3.67	3.63

Source: S&P Capital IQ. Standard template. Financial Sources.